SBIR/STTR Research Award

NEW BIOCATALYST FOR CHIRAL SYNTHESIS IN ORGANIC MEDIA

Award identifier 3de37e51b2312b164aff593079e98c8b119c948a5bdf59924fc445d09761bc8bAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$99,991

Program and phase

STTR · Phase I

Award year

2002

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
POLIUM TECHNOLOGIES, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Improvements in biocatalyst solubility, separability and reusability that would increase the utility of biocatalysis in industrial chemistry are the goals of this proposal. Based on a background of development of practical, recoverable enzymatic reagents at Polium and a background in development of novel soluble polymer supports for synthesis and catalysis at TAMU, new strategies to develop soluble but recoverable polymer-bound enzymatic reagents are proposed. Using photoresponsive groups and polyacrylamides, we propose to prepare lipase biocatalysts that will be reversibly soluble and active in different organic solvents. The polymer supports proposed below are designed to provide handles for the support and recovery of active enzymes and to incorporate pendant groups that lead to organic solvent solubility. In addition, these polymer-enzyme conjugates will incorporate photosensitive azoarenes or spirobenzopyran groups whose geometrical or structural isomerization on irradiation will change the polymer's solubility. The result will be 'smart' polymer-bound enzymes whose solubility in organic solvents can be turned on or off by photoirradiation. Target substrates for the biocatalysts based on Pseudomonas cepacia lipase will include important intermediates like beta-amino acids, ACE-inhibitors, and derivatives of 1-alkylamino-3-aryloxy-2-propanol. The homochiral versions of all of these targets have important pharmaceutical applications. PROPOSED COMMERCIAL APPLICATION: Not Available.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.